Cargando…

Evaluating the Immunogenicity and Safety of a Smallpox Vaccine to Monkeypox in Healthy Japanese Adults: A Single-Arm Study

Monkeypox (mpox) is an acute exanthematous disease caused by the monkeypox virus (MPXV). Since May 2022, patients with mpox have been reported worldwide, mainly in Europe and the Americas. In Japan, LC16”KMB,” which is a smallpox vaccine derived from a dried cell culture, against mpox, has been appr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomita, Noriko, Morino, Eriko, Terada-Hirashima, Junko, Uemura, Yukari, Shimizu, Yosuke, Saito, Sho, Suzuki, Tetsuya, Okumura, Nobumasa, Iwasaki, Haruka, Ebihara, Hideki, Shimojima, Masayuki, Sugiura, Wataru, Ohmagari, Norio, Ujiie, Mugen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059741/ https://www.ncbi.nlm.nih.gov/pubmed/36983942 http://dx.doi.org/10.3390/life13030787

Ejemplares similares

Efficacy and Safety of the Smallpox Vaccine for Postexposure Prophylaxis in Monkeypox: Protocol for an Open-Labeled, Single-Armed Study
por: Yano, Rina, et al.
Publicado: (2023)

An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox
por: Tomita, Noriko, et al.
Publicado: (2023)

Treatment with tecovirimat of the first two cases of monkeypox in Japan
por: Inada, Makoto, et al.
Publicado: (2023)

Protocol of an Exploratory Single-Arm Study to Evaluate the Safety and Immunogenicity of KD-414 as a Booster Vaccine for SARS-CoV-2 in Healthy Adults (KAPIVARA)
por: Terayama, Yuriko, et al.
Publicado: (2022)

Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults: An open-label, single-center, non-randomized, controlled study in Japan
por: Terada-Hirashima, Junko, et al.
Publicado: (2023)

Neutralising activity and antibody titre in 10 patients with breakthrough infections of the SARS-CoV-2 Omicron variant in Japan
por: Okumura, Nobumasa, et al.
Publicado: (2022)

Protocol of Tecopox study: a multicentre, open-label, double-arm trial to evaluate the efficacy and safety of oral tecovirimat therapy for patients with smallpox or monkeypox
por: Suzuki, Tetsuya, et al.
Publicado: (2023)

Efficacy and Safety of Inhaled Ciclesonide in Treating Patients With Asymptomatic or Mild COVID-19 in the RACCO Trial: Protocol for a Multicenter, Open-label, Randomized Controlled Trial
por: Terada-Hirashima, Junko, et al.
Publicado: (2020)

Varicella pneumonia in an immunocompetent, unvaccinated man: A case report
por: Okumura, Nobumasa, et al.
Publicado: (2021)

A nationwide prospective cohort study on safety of the 17D-204 yellow fever vaccine during a vaccine shortage in Japan
por: Miyazato, Yusuke, et al.
Publicado: (2022)

Effect of temperature on the infectivity of COVID-19
por: Ujiie, Mugen, et al.
Publicado: (2020)

A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT)
por: Tomita, Noriko, et al.
Publicado: (2022)

Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine
por: Yamamoto, Shohei, et al.
Publicado: (2022)

The current emergence of monkeypox: The recurrence of another smallpox?
por: Lu, Tianyu, et al.
Publicado: (2022)

Human monkeypox and smallpox viruses: genomic comparison
por: Shchelkunov, Sergei N., et al.
Publicado: (2001)

Monkeypox outbreak in the post-eradication era of smallpox
por: Kandra, Naga Vishnu, et al.
Publicado: (2023)

Smallpox, Monkeypox and Other Human Orthopoxvirus Infections
por: Shchelkunova, Galina A., et al.
Publicado: (2022)

Catch-up immunization for adolescents and young adults during pre-travel consultation in Japan
por: Yamamoto, Kei, et al.
Publicado: (2021)

Efficacy and Safety of Direct Hemoperfusion Using Polymyxin B-Immobilized Polystyrene Column for Patients With COVID-19: Protocol for an Exploratory Study
por: Terada-Hirashima, Junko, et al.
Publicado: (2022)

Clinical Epidemiology of Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan: Report of the COVID-19 Registry Japan
por: Matsunaga, Nobuaki, et al.
Publicado: (2020)

Breakthrough monkeypox infection among individuals previously immunized with smallpox or monkeypox vaccination
por: Raccagni, Angelo Roberto, et al.
Publicado: (2022)

Monkeypox Epidemic: A Throwback From Smallpox Eradication
por: Bethineedi, Lakshmi Deepak, et al.
Publicado: (2022)

A narrative review of pox: smallpox vs monkeypox
por: Jayswal, Samiksha, et al.
Publicado: (2022)

A case of varicella zoster virus meningitis following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient
por: Maruki, Taketomo, et al.
Publicado: (2021)

Can a smallpox drug treat monkeypox? Compassionate use of tecovirimat for monkeypox infection
por: Fatima, Maurish, et al.
Publicado: (2023)

SARS-CoV-2 specific T cell and humoral immune responses upon vaccination with BNT162b2: a 9 months longitudinal study
por: Takeuchi, Junko S., et al.
Publicado: (2022)

Patient Safety Tools: SARS, Smallpox, Monkeypox, and Avian Flu
por: Fishman, Marlene, et al.
Publicado: (2005)

Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections()
por: Baker, Robert O, et al.
Publicado: (2003)

An Association Study of HLA with the Kinetics of SARS-CoV-2 Spike Specific IgG Antibody Responses to BNT162b2 mRNA Vaccine
por: Khor, Seik-Soon, et al.
Publicado: (2022)

Factors affecting the likelihood of monkeypox's emergence and spread in the post-smallpox era()
por: Reynolds, Mary G, et al.
Publicado: (2012)

Human monkeypox – After 40 years, an unintended consequence of smallpox eradication
por: Simpson, Karl, et al.
Publicado: (2020)

Human monkeypox — After 40 years, an unintended consequence of smallpox eradication
por: Shah, Hussain Haider, et al.
Publicado: (2023)

Monkeypox, smallpox, FDA, and accelerated approval of vaccines – A regulatory perspective
por: Sun, Wellington
Publicado: (2023)

Antibody titers and neutralizing activity in cases of COVID-19 after a single dose of vaccination
por: Okumura, Nobumasa, et al.
Publicado: (2022)

Susceptibility of Marmosets (Callithrix jacchus) to Monkeypox Virus: A Low Dose Prospective Model for Monkeypox and Smallpox Disease
por: Mucker, Eric M., et al.
Publicado: (2015)

Monkeypox in Patient Immunized with ACAM2000 Smallpox Vaccine During 2022 Outbreak
por: Turner, Matthew, et al.
Publicado: (2022)

Antiviral activity of cyclopentenyl nucleosides against orthopox viruses (Smallpox, monkeypox and cowpox)
por: Chu, C.K, et al.
Publicado: (2003)

Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf
por: De Clercq, Erik, et al.
Publicado: (2023)

Is there any evidence for milder courses of monkeypox virus infections with childhood smallpox vaccination?
por: Hoffmann, Christian, et al.
Publicado: (2022)

Pandemic potential of poxviruses: From an ancient killer causing smallpox to the surge of monkeypox
por: Brüssow, Harald
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kd4rlkos5lge0un0nodmef1n2r